KURA:NASDAQ, Kura Oncology, Inc.
KURA stock overview
Kura Oncology, Inc. (KURA:NASDAQ) closed at $7.77 on November 13, 2026,
up 4.58% on the day.
The stock trades 44.1% below its 52-week high of $13.90
and 15.1% above its 52-week low of $6.75.
Over the past year, it lost 30.7%.
Kura Oncology, Inc. is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $7.77
- Day change
- +4.58%
- Volume
- 2,226,301
- Average volume
- 2,136,362
- Market cap
- 713M+
- 52-week range
- $6.75 – $13.90
- 50-day average
- $10.28
- 200-day average
- $9.78
Price action over the past year
In 252 trading sessions since November 13, 2025, KURA closed higher on 120 days (48%).
Its best day was May 20, 2026 (+15.40%) and its worst was November 4, 2026 (-22.98%).
The stock moved 10% or more in a single session 5 times.
It opened at least 5% above the previous day's high 3 times.
Recent signals
KURA news
-
Nov 13, 2026:
Kura Oncology to Participate in Two Investor Conferences in November
-
Nov 11, 2026:
Kura Oncology, Inc. Q3 2026 Earnings Call Summary
-
Nov 11, 2026:
Kura Oncology Inc (KURA) (Q3 2026) Earnings Call Highlights: KOMZIFTI Revenue Surges 53% as ...
-
Nov 11, 2026:
Kura Oncology (KURA) Q3 2026 Earnings Call Transcript
-
Nov 11, 2026:
Kura Oncology Q3 Earnings Call Highlights
-
Nov 10, 2026:
Kura Oncology Narrows Loss And Beats As KOMZIFTI Launch Builds, But Collaboration Cut, Dilution, And Debt Shape A Battered Stock's Setup
-
Nov 10, 2026:
Kura Oncology: Q3 Earnings Snapshot
-
Nov 10, 2026:
Kura Oncology (KURA) Reports Q3 Loss, Beats Revenue Estimates
About Kura Oncology, Inc.
Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers.
Similar stocks
Find more stocks like KURA with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.